TMPRSS11E and esophageal squamous cell carcinoma: These findings suggest that DESC1 is an important downstream effect factor of LOXL1-AS1 in regulating the progression of ESCC, so LOXL1-AS1 is expected to become a new target for the treatment of ESCC through its interaction with DESC1 protein [70].